N-(3-cyclohexyloxy-1-methylindazol-6-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine;N-[3-(cyclopenten-1-yl)-1-methylindazol-6-yl]-1H-pyrazolo[4,3-b]pyridin-3-amine;N-[1-methyl-3-[2-(2-methylphenoxy)ethoxy]indazol-6-yl]-1H-pyrazolo[4,3-b]pyridin-3-amine;1-methyl-3-[1-methyl-6-(1H-pyrazolo[4,3-b]pyridin-3-ylamino)indazol-3-yl]pyridin-2-one;N-[1-methyl-3-(3-phenoxypropoxy)indazol-6-yl]-1H-pyrazolo[4,3-b]pyridin-3-amine

C105H101N31O6 — CID 158682995

IUPACN-(3-cyclohexyloxy-1-methylindazol-6-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine;N-[3-(cyclopenten-1-yl)-1-methylindazol-6-yl]-1H-pyrazolo[4,3-b]pyridin-3-amine;N-[1-methyl-3-[2-(2-methylphenoxy)ethoxy]indazol-6-yl]-1H-pyrazolo[4,3-b]pyridin-3-amine;1-methyl-3-[1-methyl-6-(1H-pyrazolo[4,3-b]pyridin-3-ylamino)indazol-3-yl]pyridin-2-one;N-[1-methyl-3-(3-phenoxypropoxy)indazol-6-yl]-1H-pyrazolo[4,3-b]pyridin-3-amine
SMILESCc1ccccc1OCCOc1nn(C)c2cc(Nc3n[nH]c4cccnc34)ccc12.Cn1cccc(-c2nn(C)c3cc(Nc4n[nH]c5cccnc45)ccc23)c1=O.Cn1nc(C2=CCCC2)c2ccc(Nc3n[nH]c4cccnc34)cc21.Cn1nc(OC2CCCCC2)c2ccc(Nc3n[nH]c4cccnc34)cc21.Cn1nc(OCCCOc2ccccc2)c2ccc(Nc3n[nH]c4cccnc34)cc21
InChIInChI=1S/2C23H22N6O2.C20H17N7O.C20H22N6O.C19H18N6/c1-15-6-3-4-8-20(15)30-12-13-31-23-17-10-9-16(14-19(17)29(2)28-23)25-22-21-18(26-27-22)7-5-11-24-21;1-29-20-15-16(25-22-21-19(26-27-22)9-5-12-24-21)10-11-18(20)23(28-29)31-14-6-13-30-17-7-3-2-4-8-17;1-26-10-4-5-14(20(26)28)17-13-8-7-12(11-16(13)27(2)25-17)22-19-18-15(23-24-19)6-3-9-21-18;1-26-17-12-13(22-19-18-16(23-24-19)8-5-11-21-18)9-10-15(17)20(25-26)27-14-6-3-2-4-7-14;1-25-16-11-13(21-19-18-15(22-23-19)7-4-10-20-18)8-9-14(16)17(24-25)12-5-2-3-6-12/h3-11,14H,12-13H2,1-2H3,(H2,25,26,27);2-5,7-12,15H,6,13-14H2,1H3,(H2,25,26,27);3-11H,1-2H3,(H2,22,23,24);5,8-12,14H,2-4,6-7H2,1H3,(H2,22,23,24);4-5,7-11H,2-3,6H2,1H3,(H2,21,22,23)
InChIKeyIFJMCPYETWDCGM-UHFFFAOYSA-N
MW1893.17 g/mol
LogP20.20
Rot. Bonds25

About N-(3-cyclohexyloxy-1-methylindazol-6-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine;N-[3-(cyclopenten-1-yl)-1-methylindazol-6-yl]-1H-pyrazolo[4,3-b]pyridin-3-amine;N-[1-methyl-3-[2-(2-methylphenoxy)ethoxy]indazol-6-yl]-1H-pyrazolo[4,3-b]pyridin-3-amine;1-methyl-3-[1-methyl-6-(1H-pyrazolo[4,3-b]pyridin-3-ylamino)indazol-3-yl]pyridin-2-one;N-[1-methyl-3-(3-phenoxypropoxy)indazol-6-yl]-1H-pyrazolo[4,3-b]pyridin-3-amine

N-(3-cyclohexyloxy-1-methylindazol-6-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine;N-[3-(cyclopenten-1-yl)-1-methylindazol-6-yl]-1H-pyrazolo[4,3-b]pyridin-3-amine;N-[1-methyl-3-[2-(2-methylphenoxy)ethoxy]indazol-6-yl]-1H-pyrazolo[4,3-b]pyridin-3-amine;1-methyl-3-[1-methyl-6-(1H-pyrazolo[4,3-b]pyridin-3-ylamino)indazol-3-yl]pyridin-2-one;N-[1-methyl-3-(3-phenoxypropoxy)indazol-6-yl]-1H-pyrazolo[4,3-b]pyridin-3-amine (PubChem CID 158682995) has the molecular formula C105H101N31O6 and a molecular weight of 1893.17 g/mol. Its IUPAC name is N-(3-cyclohexyloxy-1-methylindazol-6-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine;N-[3-(cyclopenten-1-yl)-1-methylindazol-6-yl]-1H-pyrazolo[4,3-b]pyridin-3-amine;N-[1-methyl-3-[2-(2-methylphenoxy)ethoxy]indazol-6-yl]-1H-pyrazolo[4,3-b]pyridin-3-amine;1-methyl-3-[1-methyl-6-(1H-pyrazolo[4,3-b]pyridin-3-ylamino)indazol-3-yl]pyridin-2-one;N-[1-methyl-3-(3-phenoxypropoxy)indazol-6-yl]-1H-pyrazolo[4,3-b]pyridin-3-amine.

Molecular Properties

Compound NameN-(3-cyclohexyloxy-1-methylindazol-6-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine;N-[3-(cyclopenten-1-yl)-1-methylindazol-6-yl]-1H-pyrazolo[4,3-b]pyridin-3-amine;N-[1-methyl-3-[2-(2-methylphenoxy)ethoxy]indazol-6-yl]-1H-pyrazolo[4,3-b]pyridin-3-amine;1-methyl-3-[1-methyl-6-(1H-pyrazolo[4,3-b]pyridin-3-ylamino)indazol-3-yl]pyridin-2-one;N-[1-methyl-3-(3-phenoxypropoxy)indazol-6-yl]-1H-pyrazolo[4,3-b]pyridin-3-amine
PubChem CID158682995
Molecular FormulaC105H101N31O6
Molecular Weight1893.17 g/mol
Exact Mass1891.86
IUPAC NameN-(3-cyclohexyloxy-1-methylindazol-6-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine;N-[3-(cyclopenten-1-yl)-1-methylindazol-6-yl]-1H-pyrazolo[4,3-b]pyridin-3-amine;N-[1-methyl-3-[2-(2-methylphenoxy)ethoxy]indazol-6-yl]-1H-pyrazolo[4,3-b]pyridin-3-amine;1-methyl-3-[1-methyl-6-(1H-pyrazolo[4,3-b]pyridin-3-ylamino)indazol-3-yl]pyridin-2-one;N-[1-methyl-3-(3-phenoxypropoxy)indazol-6-yl]-1H-pyrazolo[4,3-b]pyridin-3-amine
SMILESCc1ccccc1OCCOc1nn(C)c2cc(Nc3n[nH]c4cccnc34)ccc12.Cn1cccc(-c2nn(C)c3cc(Nc4n[nH]c5cccnc45)ccc23)c1=O.Cn1nc(C2=CCCC2)c2ccc(Nc3n[nH]c4cccnc34)cc21.Cn1nc(OC2CCCCC2)c2ccc(Nc3n[nH]c4cccnc34)cc21.Cn1nc(OCCCOc2ccccc2)c2ccc(Nc3n[nH]c4cccnc34)cc21
InChIInChI=1S/2C23H22N6O2.C20H17N7O.C20H22N6O.C19H18N6/c1-15-6-3-4-8-20(15)30-12-13-31-23-17-10-9-16(14-19(17)29(2)28-23)25-22-21-18(26-27-22)7-5-11-24-21;1-29-20-15-16(25-22-21-19(26-27-22)9-5-12-24-21)10-11-18(20)23(28-29)31-14-6-13-30-17-7-3-2-4-8-17;1-26-10-4-5-14(20(26)28)17-13-8-7-12(11-16(13)27(2)25-17)22-19-18-15(23-24-19)6-3-9-21-18;1-26-17-12-13(22-19-18-16(23-24-19)8-5-11-21-18)9-10-15(17)20(25-26)27-14-6-3-2-4-7-14;1-25-16-11-13(21-19-18-15(22-23-19)7-4-10-20-18)8-9-14(16)17(24-25)12-5-2-3-6-12/h3-11,14H,12-13H2,1-2H3,(H2,25,26,27);2-5,7-12,15H,6,13-14H2,1H3,(H2,25,26,27);3-11H,1-2H3,(H2,22,23,24);5,8-12,14H,2-4,6-7H2,1H3,(H2,22,23,24);4-5,7-11H,2-3,6H2,1H3,(H2,21,22,23)
InChIKeyIFJMCPYETWDCGM-UHFFFAOYSA-N
XLogP20.20
TPSA425.25 Ų
H-Bond Donors10
H-Bond Acceptors32
Rotatable Bonds25
Heavy Atoms142
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001893.17
LogP ≤ 520.20
H-Bond Donors ≤ 510
H-Bond Acceptors ≤ 1032

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}

Analyze N-(3-cyclohexyloxy-1-methylindazol-6-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine;N-[3-(cyclopenten-1-yl)-1-methylindazol-6-yl]-1H-pyrazolo[4,3-b]pyridin-3-amine;N-[1-methyl-3-[2-(2-methylphenoxy)ethoxy]indazol-6-yl]-1H-pyrazolo[4,3-b]pyridin-3-amine;1-methyl-3-[1-methyl-6-(1H-pyrazolo[4,3-b]pyridin-3-ylamino)indazol-3-yl]pyridin-2-one;N-[1-methyl-3-(3-phenoxypropoxy)indazol-6-yl]-1H-pyrazolo[4,3-b]pyridin-3-amine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-(3-cyclohexyloxy-1-methylindazol-6-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine;N-[3-(cyclopenten-1-yl)-1-methylindazol-6-yl]-1H-pyrazolo[4,3-b]pyridin-3-amine;N-[1-methyl-3-[2-(2-methylphenoxy)ethoxy]indazol-6-yl]-1H-pyrazolo[4,3-b]pyridin-3-amine;1-methyl-3-[1-methyl-6-(1H-pyrazolo[4,3-b]pyridin-3-ylamino)indazol-3-yl]pyridin-2-one;N-[1-methyl-3-(3-phenoxypropoxy)indazol-6-yl]-1H-pyrazolo[4,3-b]pyridin-3-amine?
The IUPAC name of N-(3-cyclohexyloxy-1-methylindazol-6-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine;N-[3-(cyclopenten-1-yl)-1-methylindazol-6-yl]-1H-pyrazolo[4,3-b]pyridin-3-amine;N-[1-methyl-3-[2-(2-methylphenoxy)ethoxy]indazol-6-yl]-1H-pyrazolo[4,3-b]pyridin-3-amine;1-methyl-3-[1-methyl-6-(1H-pyrazolo[4,3-b]pyridin-3-ylamino)indazol-3-yl]pyridin-2-one;N-[1-methyl-3-(3-phenoxypropoxy)indazol-6-yl]-1H-pyrazolo[4,3-b]pyridin-3-amine (CID 158682995) is N-(3-cyclohexyloxy-1-methylindazol-6-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine;N-[3-(cyclopenten-1-yl)-1-methylindazol-6-yl]-1H-pyrazolo[4,3-b]pyridin-3-amine;N-[1-methyl-3-[2-(2-methylphenoxy)ethoxy]indazol-6-yl]-1H-pyrazolo[4,3-b]pyridin-3-amine;1-methyl-3-[1-methyl-6-(1H-pyrazolo[4,3-b]pyridin-3-ylamino)indazol-3-yl]pyridin-2-one;N-[1-methyl-3-(3-phenoxypropoxy)indazol-6-yl]-1H-pyrazolo[4,3-b]pyridin-3-amine.
What is the SMILES notation for N-(3-cyclohexyloxy-1-methylindazol-6-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine;N-[3-(cyclopenten-1-yl)-1-methylindazol-6-yl]-1H-pyrazolo[4,3-b]pyridin-3-amine;N-[1-methyl-3-[2-(2-methylphenoxy)ethoxy]indazol-6-yl]-1H-pyrazolo[4,3-b]pyridin-3-amine;1-methyl-3-[1-methyl-6-(1H-pyrazolo[4,3-b]pyridin-3-ylamino)indazol-3-yl]pyridin-2-one;N-[1-methyl-3-(3-phenoxypropoxy)indazol-6-yl]-1H-pyrazolo[4,3-b]pyridin-3-amine?
The canonical SMILES for N-(3-cyclohexyloxy-1-methylindazol-6-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine;N-[3-(cyclopenten-1-yl)-1-methylindazol-6-yl]-1H-pyrazolo[4,3-b]pyridin-3-amine;N-[1-methyl-3-[2-(2-methylphenoxy)ethoxy]indazol-6-yl]-1H-pyrazolo[4,3-b]pyridin-3-amine;1-methyl-3-[1-methyl-6-(1H-pyrazolo[4,3-b]pyridin-3-ylamino)indazol-3-yl]pyridin-2-one;N-[1-methyl-3-(3-phenoxypropoxy)indazol-6-yl]-1H-pyrazolo[4,3-b]pyridin-3-amine is Cc1ccccc1OCCOc1nn(C)c2cc(Nc3n[nH]c4cccnc34)ccc12.Cn1cccc(-c2nn(C)c3cc(Nc4n[nH]c5cccnc45)ccc23)c1=O.Cn1nc(C2=CCCC2)c2ccc(Nc3n[nH]c4cccnc34)cc21.Cn1nc(OC2CCCCC2)c2ccc(Nc3n[nH]c4cccnc34)cc21.Cn1nc(OCCCOc2ccccc2)c2ccc(Nc3n[nH]c4cccnc34)cc21.
What is the InChIKey of N-(3-cyclohexyloxy-1-methylindazol-6-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine;N-[3-(cyclopenten-1-yl)-1-methylindazol-6-yl]-1H-pyrazolo[4,3-b]pyridin-3-amine;N-[1-methyl-3-[2-(2-methylphenoxy)ethoxy]indazol-6-yl]-1H-pyrazolo[4,3-b]pyridin-3-amine;1-methyl-3-[1-methyl-6-(1H-pyrazolo[4,3-b]pyridin-3-ylamino)indazol-3-yl]pyridin-2-one;N-[1-methyl-3-(3-phenoxypropoxy)indazol-6-yl]-1H-pyrazolo[4,3-b]pyridin-3-amine?
The InChIKey is IFJMCPYETWDCGM-UHFFFAOYSA-N. The full InChI is InChI=1S/2C23H22N6O2.C20H17N7O.C20H22N6O.C19H18N6/c1-15-6-3-4-8-20(15)30-12-13-31-23-17-10-9-16(14-19(17)29(2)28-23)25-22-21-18(26-27-22)7-5-11-24-21;1-29-20-15-16(25-22-21-19(26-27-22)9-5-12-24-21)10-11-18(20)23(28-29)31-14-6-13-30-17-7-3-2-4-8-17;1-26-10-4-5-14(20(26)28)17-13-8-7-12(11-16(13)27(2)25-17)22-19-18-15(23-24-19)6-3-9-21-18;1-26-17-12-13(22-19-18-16(23-24-19)8-5-11-21-18)9-10-15(17)20(25-26)27-14-6-3-2-4-7-14;1-25-16-11-13(21-19-18-15(22-23-19)7-4-10-20-18)8-9-14(16)17(24-25)12-5-2-3-6-12/h3-11,14H,12-13H2,1-2H3,(H2,25,26,27);2-5,7-12,15H,6,13-14H2,1H3,(H2,25,26,27);3-11H,1-2H3,(H2,22,23,24);5,8-12,14H,2-4,6-7H2,1H3,(H2,22,23,24);4-5,7-11H,2-3,6H2,1H3,(H2,21,22,23).
What are the key properties of N-(3-cyclohexyloxy-1-methylindazol-6-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine;N-[3-(cyclopenten-1-yl)-1-methylindazol-6-yl]-1H-pyrazolo[4,3-b]pyridin-3-amine;N-[1-methyl-3-[2-(2-methylphenoxy)ethoxy]indazol-6-yl]-1H-pyrazolo[4,3-b]pyridin-3-amine;1-methyl-3-[1-methyl-6-(1H-pyrazolo[4,3-b]pyridin-3-ylamino)indazol-3-yl]pyridin-2-one;N-[1-methyl-3-(3-phenoxypropoxy)indazol-6-yl]-1H-pyrazolo[4,3-b]pyridin-3-amine?
N-(3-cyclohexyloxy-1-methylindazol-6-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine;N-[3-(cyclopenten-1-yl)-1-methylindazol-6-yl]-1H-pyrazolo[4,3-b]pyridin-3-amine;N-[1-methyl-3-[2-(2-methylphenoxy)ethoxy]indazol-6-yl]-1H-pyrazolo[4,3-b]pyridin-3-amine;1-methyl-3-[1-methyl-6-(1H-pyrazolo[4,3-b]pyridin-3-ylamino)indazol-3-yl]pyridin-2-one;N-[1-methyl-3-(3-phenoxypropoxy)indazol-6-yl]-1H-pyrazolo[4,3-b]pyridin-3-amine has a molecular weight of 1893.17 g/mol, XLogP of 20.20, 25 rotatable bonds, 10 hydrogen bond donors, and 32 hydrogen bond acceptors.
Where does this data come from?
All data for N-(3-cyclohexyloxy-1-methylindazol-6-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine;N-[3-(cyclopenten-1-yl)-1-methylindazol-6-yl]-1H-pyrazolo[4,3-b]pyridin-3-amine;N-[1-methyl-3-[2-(2-methylphenoxy)ethoxy]indazol-6-yl]-1H-pyrazolo[4,3-b]pyridin-3-amine;1-methyl-3-[1-methyl-6-(1H-pyrazolo[4,3-b]pyridin-3-ylamino)indazol-3-yl]pyridin-2-one;N-[1-methyl-3-(3-phenoxypropoxy)indazol-6-yl]-1H-pyrazolo[4,3-b]pyridin-3-amine is sourced from PubChem (CID 158682995), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).